Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Payors Weigh in on Interface of Personalized Medicine and Comparative Effectiveness Research
December 08, 2010
While payors speaking at a recent conference seemed to be of the opinion that personalized medicine lacks the evidentiary support to justify broad coverage, they suggested that CER may be a way to gather the necessary data on whether to reimburse for genomically guided medicines.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- Aurora to Use Oracle's Informatics Muscle to Run More Efficient Clinical Trials; PGx in Long View
February 9, 2011 / Pharmacogenomics Reporter - Will PCORI's Patient-Centered Comparative Effectiveness Research Track with Personalized Rx?
March 7, 2012 / Pharmacogenomics Reporter - Absent 'Gold Standard' for HER2 Testing, Researchers Question Role of Oncotype DX Beyond IHC/FISH
December 21, 2011 / Pharmacogenomics Reporter - San Antonio Breast Cancer Symposium Presentations Highlight Personalized Cancer Treatment
December 14, 2011 / Pharmacogenomics Reporter - FDA Rejects Avastin as Breast Cancer Drug; Genentech to Conduct New Trial to ID Best Responders
November 30, 2011 / Pharmacogenomics Reporter